Cargando…
Introduction and clearance of beta‐glucan in the downstream processing of monoclonal antibodies
β‐Glucan process‐related impurities can be introduced into biopharmaceutical products via upstream or downstream processing or via excipients. This study obtained a comprehensive process‐mapping dataset for five monoclonal antibodies to assess β‐glucan introduction and clearance during development a...
Autores principales: | Kluters, Simon, Steinhauser, Karin, Pfänder, Roland, Studts, Joey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9285507/ https://www.ncbi.nlm.nih.gov/pubmed/33743183 http://dx.doi.org/10.1002/btpr.3149 |
Ejemplares similares
-
Antibody-Mediated Clearance of Brain Amyloid-β: Mechanisms of Action, Effects of Natural and Monoclonal Anti-Aβ Antibodies, and Downstream Effects
por: Loeffler, David A.
Publicado: (2023) -
In-line monitoring of surfactant clearance in viral vaccine downstream processing
por: Payne, Jessie, et al.
Publicado: (2021) -
Prediction and Reduction of the Aggregation of Monoclonal Antibodies
por: van der Kant, Rob, et al.
Publicado: (2017) -
Monoclonal Antibodies Capable of Inhibiting Complement Downstream of C5 in Multiple Species
por: Zelek, Wioleta M., et al.
Publicado: (2020) -
Novel mouse monoclonal antibodies specifically recognizing β-(1→3)-D-glucan antigen
por: Matveev, Andrey L., et al.
Publicado: (2019)